Petren+Mallmin M., Nordstrom B., Andreasson I.
MR imaging with histopatholigical
correlation in vertebral metastases of breast cancer // Acta Radiol. — 1992. — V. 33 (3). —
P. 213 220.
Petren+Mallmin M.
Clinical and experimental imaging of breast cancer metastases in
the spine // Acta Radiol. Suppl. — 1994. — V. 391. — P. 1 23.
Piccart M.
Treatment of advanced breast cancer: current status // Anti Cancer
Drugs. — 1996. — V. 7(Suppl. 2). — P. 5 7.
Piovesan A., Berruti A., Osella G., Raucci C.A., Torta M., Dogliotti L., Angeli A.
Serum levels of carboxyterminal propeptide of type I procollagen in cancer patients with
osteoblastic and osteolytic bone metastases // Int. J. Biol. Markers. — 1994. — V. 9(4). —
P. 243 246.
Pizzocaro C., Panarotto M.B., De Agostini A.
Experience with 89 strontium treat
ment of painful osseus metastases from breast cancer // Tumori. — 1997. — V. 83. —
P.558 559.
Plumb M., Holland J.
Comparative studies of psychological function in patients with
advanced cancer. I. Self reported depressive symptoms // Psychosom. Med. — 1977. —
V. 39. — P. 264 276.
Plosker G.L., Goa K.L.
Clodronate. A Review of its pharmacological properties and
therapeutic efficacy in resorptive bone disease // Drugs 47. — 1994. — V. 47. — P. 945 982.
Pons F., Herranz R., Garcia A., Vidal+Sicart S., Conill C., Grau J.J., Alcover J., Fuster
D., Setoain J.
Strontium 89 for palliation of pain from bone metastases in patients with
prostate and breast cancer // Eur. J. Nucl. Med. — 1997. — V. 24(10). — P. 1210 1214.
Popiela T., Lucchi R., Giongo F.
Methilprednisolon as palliative therapy for female
terminal cancer patients // Eur. J. Clin. Oncol. — 1989. — V. 25(12). — P. 1823 1829.
Portenoy R.K., Moulin D.E., Rogers A.,
è ñîàâò. I.v. infusion of opioidsfor cancer
pain: clinical revuew and guidelines for use // Cancer Treat. Rep. — 1986. — V. 70(5). —
P. 575 581.
Porter A.T., Ben+Josef E., Davis L.
Systemic administration of new therapeutic
radioisotopes, including phosphorus, strontium, samarium, and rhenium // Curr. Opin.
Oncol. — 1994. — V. 6(6). — P. 607 610.
Powsner R.A., Zietman A.L., Foss F.M.
Bone marrow suppression after strontium 89
therapy and local radiation therapy in patients with diffuse marrow involvement // Clin.
Nucl. Med. — 1997. — V. 22(3). — P. 147 150.
Price P., Hoskin P.J., Easton D.
Low dose single fraction radiotherapy in the treat
ment of metastatic bone pain // Radiother. Oncol. — 1988. — V. 12. — P. 297 300.
Price J.E
. The biology of metastatic breast cancer // Cancer. — 1990. — V. 15(66). —
P.1313 1320.
Purohit O.P., Radstone C.R., Anthony C., Kanis J.A., Coleman R.E.
A randomised
double blind comparison of intravenous pamidronate and clodronate in the hypercal
caemia of malignancy // Br. J. Cancer. — 1995. — V. 72(5). — P. 1289 1293.
Purohit O.P., Anthony C., Radstone C.R., Owen J., Coleman R.E.
High dose intra
venous pamidronate for metastatic bone pain // Br. J. Cancer. — 1996. — V. 70. — P. 554
558.
Radbruch L., Zech D., Grond S.
Therapy for symptomatic pain in advanced breast
cancer // Geburtshilfe Frauenheilkd. — 1992. — V. 52 (7). — P. 404 411.
Rafii M., Firooznia H., Golimbu C., Berambaum E.
CT of skeletal metastasis // Selim
ultrasound. CT, MR. — 1986. — V. 7. — P. 371 379.
243
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
